Meet our team

Founder

Chief Executive Officer (CEO)

Jenestin Anthonipillai

Jenestin Anthonipillai profile picture

Jenestin uniquely merges technical know-how with exceptional problem-solving skills. With a Swiss Mobility Master's in Computer Science, he followed Computer Science Master courses at EPFL, while also obtaining entrepreneurial insights at the University of St. Gallen. Jenestin, formerly a research and teaching assistant in statistics under Professor Siegfried Handschuh, now specializes in AI for chemistry under the supervision of Professor Philippe Schwaller. His journey includes valuable interactions with global leaders like André Hoffman from Roche Holding and Sal Khan from Khan Academy, embodying a commitment to innovation and collaboration.


Founder

Chief Technology Officer (CTO)

Naravich Chutisilp

Naravich Chutisilp profile picture

Naravich, an EPFL MSc. CS student, brings a wealth of expertise in medical imaging AI research to medikan. He has been awarded the gold medal for his highest GPA during his Bachelor of Engineering program at Chulalongkorn University. He has conducted numerous medical imaging researches under Prof. Dr. Mary-Anne Hartley, Dr. Jean-Marc Odobez, Prof. Dr. Ekapol Chuangsuwanich, and Prof. Dr. Proadpran Punyabukkana. Naravich will also be completing his MSc. thesis on multimodal medical imaging AI at MIT under the guidance of Prof. Dr. Elazer R. Edelman.



Founder

Chief Medical Officer (CMO)

Prof. Dr. med. Bruno Fuchs

Prof. Dr. med. Bruno Fuchs profile picture

Prof. Dr. med. Bruno Fuchs, Chief Physician and Head of Orthopaedic Tumor Surgery at the Department of Orthopaedics and Traumatology, also leads the Sarcoma Center. Specializing in diagnosing and treating musculoskeletal tumors, Prof. Dr. med. Bruno Fuchs provides comprehensive patient care, coordinates Sarcoma Board activities, performs biopsies in collaboration with radiologists, and conducts surgical removal and reconstruction for a range of tumors in both children and adults, including osteosarcoma, Ewing's sarcoma, chondrosarcoma, and soft tissue tumors. He is dedicated to advancing healthcare, seeks to bring innovation into hospitals through his expertise.